• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 PAMAM 树状高分子的辛伐他汀制剂的性能评价。

Performance evaluation of PAMAM dendrimer based simvastatin formulations.

机构信息

Institute of Pharmacy, Bundelkhand University, Jhansi, UP 284128, India.

出版信息

Int J Pharm. 2011 Feb 28;405(1-2):203-9. doi: 10.1016/j.ijpharm.2010.12.002. Epub 2010 Dec 9.

DOI:10.1016/j.ijpharm.2010.12.002
PMID:21145960
Abstract

The purpose of this investigation was to evaluate the performance of poly (amidoamine) (PAMAM) dendrimers, with three different surface groups, to be used as drug carriers. Drug-dendrimers complexes were investigated for solubility studies, dissolution studies, in vitro drug release studies, and for stability studies. The solubility enhancement was found maximum with PEGylated dendrimers (33 times) followed by amine (23 times) and hydroxyl (17.5 times) dendrimers. The solubility profile of simvastatin-dendrimer complex showed a linear correlation (Higuchi A(L)-type diagram) between solubility and dendrimers concentration. The formation of the complexes between drug molecules and dendrimers were characterized by the FTIR spectra of these complexes, showing the appearance of the bond formed between the functional groups of the drug (OH and COOH) and dendrimers (NH(2) and OH). The drug-dendrimer complexes displayed the controlled release action during in vitro release studies. Pure simvastatin (SMV) was released in 5h whereas the PEGylated dendrimers-SMV complexes released the drug up to 5 days. The non-PEGylated formulations released the drug up to 24h. Formulations with amine and PEGylated dendrimers were subjected to accelerated stability studies. Formulations with amine dendrimers were found to be most stable in dark, low temperature (0°C) whereas the dark, RT was most suitable storage conditions for formulation with PEGylated dendrimers.

摘要

本研究旨在评估具有三种不同表面基团的聚酰胺-胺(PAMAM)树枝状大分子作为药物载体的性能。研究了药物-树枝状大分子复合物的溶解度研究、溶解研究、体外药物释放研究和稳定性研究。发现聚乙二醇化树枝状大分子(提高 33 倍)、胺(提高 23 倍)和羟基(提高 17.5 倍)树枝状大分子的增溶效果最大。辛伐他汀-树枝状大分子复合物的溶解度曲线显示了溶解度与树枝状大分子浓度之间的线性相关性(Higuchi A(L)-型图)。药物分子与树枝状大分子之间形成复合物的特征是这些复合物的傅里叶变换红外光谱(FTIR),显示出药物(OH 和 COOH)和树枝状大分子(NH(2)和 OH)的官能团之间形成的键。药物-树枝状大分子复合物在体外释放研究中显示出控制释放作用。纯辛伐他汀(SMV)在 5 小时内释放,而聚乙二醇化树枝状大分子-SMV 复合物则在 5 天内释放药物。非聚乙二醇化制剂在 24 小时内释放药物。对含有胺和聚乙二醇化树枝状大分子的制剂进行了加速稳定性研究。含有胺树枝状大分子的制剂在黑暗、低温(0°C)下最稳定,而含有聚乙二醇化树枝状大分子的制剂在黑暗、RT 下最适合储存。

相似文献

1
Performance evaluation of PAMAM dendrimer based simvastatin formulations.基于 PAMAM 树状高分子的辛伐他汀制剂的性能评价。
Int J Pharm. 2011 Feb 28;405(1-2):203-9. doi: 10.1016/j.ijpharm.2010.12.002. Epub 2010 Dec 9.
2
Pharmacokinetic and pharmacodynamic studies of poly(amidoamine) dendrimer based simvastatin oral formulations for the treatment of hypercholesterolemia.基于聚(酰胺胺)树枝状大分子的辛伐他汀口服制剂治疗高胆固醇血症的药代动力学和药效学研究。
Mol Pharm. 2013 Jul 1;10(7):2528-33. doi: 10.1021/mp300650y. Epub 2013 Jun 4.
3
Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide.聚(酰胺胺)树枝状大分子介导的雷米普利和氢氯噻嗪联合治疗混合制剂
Eur J Pharm Sci. 2017 Jan 1;96:84-92. doi: 10.1016/j.ejps.2016.09.005. Epub 2016 Sep 8.
4
Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug.以磺胺甲恶唑(SMZ)为模型药物评估聚酰胺-胺(PAMAM)树枝状大分子作为抗菌药物载体的性能。
Eur J Med Chem. 2007 Jan;42(1):93-8. doi: 10.1016/j.ejmech.2006.07.015. Epub 2006 Nov 7.
5
Dendimer-mediated solubilization, formulation development and in vitro-in vivo assessment of piroxicam.树枝状聚合物介导的吡罗昔康增溶、制剂研发及体内外评价
Mol Pharm. 2009 May-Jun;6(3):940-50. doi: 10.1021/mp8002489.
6
Thermosensitive properties of poly(amidoamine) dendrimers with peripheral phenylalanine residues.具有外周苯丙氨酸残基的聚(酰胺胺)树枝状大分子的热敏性质。
Langmuir. 2006 May 23;22(11):4920-2. doi: 10.1021/la060066t.
7
Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies.基于包封研究的聚(酰胺胺)树枝状大分子作为喜树碱药物载体的潜力。
Eur J Med Chem. 2008 Aug;43(8):1791-5. doi: 10.1016/j.ejmech.2007.09.030. Epub 2007 Dec 7.
8
Interaction between PAMAM-NH₂ G4 dendrimer and 5-fluorouracil in aqueous solution.水溶液中 PAMAM-NH₂ G4 树枝状大分子与 5-氟尿嘧啶的相互作用。
Int J Pharm. 2011 Apr 15;408(1-2):266-70. doi: 10.1016/j.ijpharm.2011.02.014. Epub 2011 Feb 16.
9
G5 PAMAM dendrimer versus liposome: a comparison study on the in vitro transepithelial transport and in vivo oral absorption of simvastatin.G5聚酰胺-胺型树枝状大分子与脂质体:辛伐他汀体外跨上皮转运及体内口服吸收的比较研究
Nanomedicine. 2015 Jul;11(5):1141-51. doi: 10.1016/j.nano.2015.02.011. Epub 2015 Mar 16.
10
Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins.聚酰胺 - 胺(PAMAM)树枝状大分子和环糊精对实际难溶的氯硝柳胺的水相增溶作用比较。
Int J Pharm. 2005 Nov 4;304(1-2):193-209. doi: 10.1016/j.ijpharm.2005.07.023. Epub 2005 Sep 27.

引用本文的文献

1
In Vitro and In Vivo Appraisal of Glycerylmonostearate/chitosan Hybrid Nanocapsules As Peroral Delivery System of Simvastatin.单硬脂酸甘油酯/壳聚糖混合纳米胶囊作为辛伐他汀口服给药系统的体外和体内评价
AAPS PharmSciTech. 2025 May 20;26(5):143. doi: 10.1208/s12249-025-03135-2.
2
Nanocarriers for Delivery of Anticancer Drugs: Current Developments, Challenges, and Perspectives.用于抗癌药物递送的纳米载体:当前进展、挑战与展望
Pharmaceutics. 2024 Nov 27;16(12):1527. doi: 10.3390/pharmaceutics16121527.
3
Development of Epigallocatechin and Ascorbic Acid Dual Delivery Transferosomes for Managing Alzheimer's Disease: In Vitro and in Vivo Studies.
用于治疗阿尔茨海默病的表没食子儿茶素和抗坏血酸双递送传递体的研发:体外和体内研究
ACS Omega. 2024 Aug 7;9(33):35463-35474. doi: 10.1021/acsomega.4c02140. eCollection 2024 Aug 20.
4
Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis.有机纳米颗粒在心血管疾病治疗与诊断进展中的应用
Polymers (Basel). 2024 May 16;16(10):1421. doi: 10.3390/polym16101421.
5
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs.增溶方法的进展:迈向提高难溶性药物生物利用度的一步。
Life (Basel). 2023 Apr 27;13(5):1099. doi: 10.3390/life13051099.
6
Emerging Nanotechnology for the Treatment of Alzheimer's Disease.新兴纳米技术治疗老年痴呆症。
CNS Neurol Disord Drug Targets. 2024;23(6):687-696. doi: 10.2174/1871527322666230501232815.
7
Dendrimer-Mediated Delivery of Anticancer Drugs for Colon Cancer Treatment.树枝状聚合物介导的抗癌药物递送用于结肠癌治疗
Pharmaceutics. 2023 Mar 1;15(3):801. doi: 10.3390/pharmaceutics15030801.
8
Highly Responsive Chitosan-Co-Poly (MAA) Nanomatrices through Cross-Linking Polymerization for Solubility Improvement.通过交联聚合制备高响应性壳聚糖-聚(甲基丙烯酸)纳米基质以改善溶解性
Gels. 2022 Mar 21;8(3):196. doi: 10.3390/gels8030196.
9
Nanoencapsulated Extract of a Red Seaweed (Rhodophyta) Species as a Promising Source of Natural Antioxidants.一种红藻(红藻门)物种的纳米封装提取物作为天然抗氧化剂的潜在来源。
ACS Omega. 2022 Feb 16;7(8):6539-6548. doi: 10.1021/acsomega.1c05517. eCollection 2022 Mar 1.
10
Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with -Glycidol and Celecoxib/Simvastatin as Repurposed Drugs and Evaluation of Their Increased Additive Cytotoxicity for Cancer Cell Lines.用缩水甘油和塞来昔布/辛伐他汀取代的生物素化聚酰胺-胺型第3代树枝状大分子的合成作为重新利用的药物及其对癌细胞系增加的相加细胞毒性评估
Cancers (Basel). 2022 Jan 29;14(3):714. doi: 10.3390/cancers14030714.